The global prefilled syringes market size is expected to reach USD 15.20 Billion in 2029, exhibiting a CAGR of 10.6% during the forecast period. The rising prevalence of diabetes can be a vital factor in favoring the growth of the market during the forecast period, states Fortune Business Insights in a report, titled “Prefilled Syringes Market Size, Share & Covid-19 Impact Analysis, and Regional Forecast, 2022-2029” the market size stood at USD 6.60 billion in 2021.
Industry Development
October 2019: BD (Becton, Dickinson, and Company) announced the launch of the BD Intevia 1mL two-step disposable autoinjector. The innovative device combines autoinjector and pre-fillable syringe in one integrated system.
Request a Free Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/prefilled-syringes-market-101946
Increasing Product Launches to Support Development in Europe
Europe is expected to witness a high growth rate during the forecast period owing to the increasing number of patients using biologics as treatment options for chronic diseases. The increasing adoption of prefilled syringes as self-injecting drug devices will further support the growth of the market in Europe. The presence of major players will boost growth in the region. Additionally, the growing introduction of a new prefilled syringe by major players will favor growth in the region. For instance, in October 2018, Fresenius Kabi announced the launch of a new prefilled syringe of palonosetron hydrochloride. North America is expected to rise tremendously during the forecast period owing to the surge in chronic diseases such as diabetes and rheumatoid arthritis. The strong distribution networks of eminent players will boost growth in North America. The market in Asia Pacific is likely to observe a significant growth rate owing to the increasing prevalence of chronic diseases and a rapidly growing patient population.
Rising Cases of Chronic Diseases to Augment Growth
The growing incidence of cancer and other non-communicable diseases is expected to spur demand for biological drugs, which, in turn, will foster the growth of the market. According to the National Cancer Institute, an estimated 1,735,530 new cancer cases were diagnosed in the U.S. in 2018. The number is expected to reach 23.6 million by 2030, thus, boosting the need for biologics. The rising shift towards prefilled syringes for the administration of biologics and biosimilars will have an excellent impact on the market during the forecast period. Similarly, the application of biologics in numerous target diseases with limited treatment options such as cancer, autoimmune diseases, and other non-communicable diseases will spur the demand of the market in the forthcoming years.
Quick Buy Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101946
Increasing Implementation of Self-Injecting Parenteral Apparatuses to Boost Market Growth
The usage of prefilled syringes as a self-inserting instrument is the contemporary method to control parenteral medications. These are appropriate and aid in simplifying the management procedure. They offer superior patient protection by dropping the latent for involuntary needle sticks and contact with contaminated products that may occur while extracting drugs from ampoules.
List of Key Players Covered in the Market Report
- BD (New Jersey, United States)
- Gerresheimer AG (Dusseldorf, Germany)
- SCHOTT AG (Mainz, Germany)
- West Pharmaceutical Services Inc. (Pennsylvania, United States)
- Helvoet Rubber & Plastic Technologies BV (Netherlands)
- Nipro PharmaPackaging International (Mechelen, Belgium)
- AptarGroup, Inc. (Illinois, United States)
- Terumo Corporation (Tokyo, Japan)
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/prefilled-syringes-market-101946
Detailed Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Global Prefilled Syringes Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Material
- Glass
- Plastic
- Market Analysis, Insights and Forecast – By Closing System
- Staked Needle System
- Luer Cone System
- Luer Lock Form System
- Market Analysis, Insights and Forecast – By Product
- Complete Syringe Set
- Components & Accessories (Backstops, Plunger Stoppers, and Plunger Rods)
- Market Analysis, Insights and Forecast – By Design
- Market Analysis, Insights and Forecast – By End User
- Pharmaceutical & Biotechnology Companies
- Contract Research & Manufacturing Organizations
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- North America Prefilled Syringes Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis – By Material
- Glass
- Plastic
- Market Analysis – By Closing System
- Staked Needle System
- Luer Cone System
- Luer Lock Form System
- Market Analysis – By Product
- Complete Syringe Set
- Components & Accessories (Backstops, Plunger Stoppers, and Plunger Rods)
- Market Analysis – By Design
- Single-chamber
- Double-chamber
- Multiple Chamber
- Market Analysis, Insights and Forecast – By End User
- Market Analysis – By Country
- U.S.
- Canada
TOC Continued…!!
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/prefilled-syringes-market-101946
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245